AbbVie Inc. announced that Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022. Mr. Michael has been AbbVie's Vice Chairman, Finance and Commercial Operations and Chief Financial Officer since December 2021. Mr. Michael previously served as AbbVie's Executive Vice President, Chief Financial Officer from October 2018 to December 2021, as AbbVie's Vice President, Controller from March 2017 until October 2018, as Vice President, Treasurer from 2015 to 2016, and as Vice President, Controller, Commercial Operations from 2013 to 2015.

Mr. Michael joined Abbott Laboratories in 1993 and held numerous positions in the finance organization. Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022. Mr. Reents previously served as Vice President, Tax and Treasury from March 2019 to June 2022, as Treasurer from January 2020 to November 2020, and as Vice President, Tax from January 2013 to March 2019.

Mr. Reents joined Abbott Laboratories in 2008 and has been with AbbVie since inception in 2013.